Our results show that mechanics, rather than biological sensing and behaviour, can explain some of the observed changes in the worm’s locomotory dynamics.”
“The roots of Cyathula officinalis Kuan are widely used in Chinese medicine for the treatment of

inflammatory disorders. Here, the ability of C. officinalis Kuan to downregulate matrix metalloproteinase (MMP)-13 was examined since MMP-13 is an important enzyme for the degradation of the cartilage collagen matrix, especially under arthritic conditions. The ethanol extract of C. officinalis Kuan as well as the n-hexane and chloroform soluble fractions were found to potently inhibit MMP-13 induction in IL-1 beta-treated SW1353 cells, a human chondrosarcoma this website cell line, at 50200 mu g/mL. Activity-guided separation led to the isolation of six compounds, palmitic acid (1), beta-sitosterol

(2), alpha-spinasterol (3), atractylenolide I (4), 1,3-diacetoxy-tetradeca-6E, 12E-dien-8,10-dyn (5), and N-trans-feruloyl-3-methyldopamine (6). Among these, 4 and 5 exhibited MMP-13 downregulating activity in IL-1 beta-treated SW1353 cells. And 4 also showed anti-oedematous activity against lambda-carageenan-induced paw edema in mice at 20-200 mg/kg, p.o. The results of this study provide information that can help elucidate the action mechanism of C. VX-661 clinical trial officinalis Kuan. In addition, the results presented here suggest that C. officinalis Kuan and its constituents may have the potential for chondroprotection against cartilage degrading disorders.”
“Oscillometric AZD1480 supplier devices are being widely used for ambulatory, home and office blood pressure ( BP) measurement. However, even successfully validated oscillometric devices fail to provide accurate measurements in some patients. This study investigated the prevalence, the reproducibility and the characteristics of the phenomenon of unreliable oscillometric BP (UOBP) measurement. A total of 5070 BP measurements were obtained simultaneously (Y connector) using a professional oscillometric device

(BpTRU) and a mercury sphygmomanometer in 755 patients (1706 visits). UOBP readings were defined as those with >10 mm Hg difference (systolic or diastolic) between the two methods. UOBP was found in 15% of systolic and 6.4% of diastolic BP measurements. In all, 18% of the participants had UOBP in their first but not their second visit, or the reverse. However, 49% of these participants had at least one more UOBP visit after their second visit within the study database. Patients with persistent UOBP were more likely to be female and had lower arm circumference. The systolic BP discrepancy between the two methods was associated with pulse pressure (r = 0.41) and inversely with diastolic BP (r = 0.40) and arm circumference (r = 0.30), whereas the diastolic discrepancy with diastolic BP (r = 0.61) and inversely with pulse pressure (r = 0.32).